Evidence Before Action.
Know what matters before every customer conversation. DOSSIRI accumulates account intelligence, monitors relevant signals, and prepares regulated-industry sales professionals with evidence — not opinions.
CRMs are built for your company. DOSSIRI is built for you.
Traditional CRMs are designed to give your organization visibility — pipeline reports, account records, forecast accuracy. They are valuable tools. But visibility for management is not the same as preparation for sellers.
Before an important conversation, the seller still has to assemble what changed, which claims are verified, which stakeholders matter, and what questions need to be answered.
A management system can record the work after the fact. DOSSIRI is built to help you prepare before the conversation, with account context organized around seller judgment.
One workspace. Everything you need to know.
Account Intelligence
Every account and prospect has a workspace. As deals progress and signals surface, DOSSIRI synthesizes what matters — so over time, each account becomes more intelligent, not just more documented.
Signal Monitoring
DOSSIRI monitors regulatory activity, clinical trial postings, and company signals across both your active accounts and the prospects you're working to win. When something changes that matters, it surfaces in your workspace.
Pre-Call Preparation
When you're ready to engage, request a pre-call brief. DOSSIRI draws on your private account context, accumulated signals, and current regulatory intelligence — so every conversation starts with evidence, not assumptions.
Built for regulated industry. Not adapted for it.
The intelligence builds as you work.
DOSSIRI turns each account into a living memory. The context you add, the signals it monitors, and the evidence it connects stay organized by account instead of disappearing into disconnected records and searches.
The more evidence accumulates, the more useful each account becomes.
NCT05982134 posted Phase III results on June 2. Primary endpoint met. Likely to accelerate outsourcing decisions in Q3 manufacturing pipeline.
Monitored by DOSSIRI · June 3, 2026
Self-reported 21 CFR Part 11 compliance on website — not independently verified. Raised in April call. Team did not confirm.
Flagged by DOSSIRI · April 2026
VP of Quality confirmed evaluation window opens Q3. Board meeting in August is the decision gate.
Added by you · May 2026
Assessment based on evidence
Assessments, not guesses.
DOSSIRI doesn't reduce an opportunity to a single number. That kind of certainty can hide uncertainty. Instead, it gives you a structured assessment of the opportunity — what the evidence supports, what's uncertain, and what needs to be answered.
Human judgment stays in the seat.
Three workflows. One workspace.
Build Your Account Workspace
Add accounts, contacts, deals, and evidence. DOSSIRI starts accumulating. The CRM core works without AI — so your data is always yours, always structured, always available.
Intelligence Accumulates
Signal monitoring surfaces what changed across your accounts and prospects. ICP analysis assesses fit. Compliance context, regulatory activity, and company signals accumulate in the background — organized by account, ready when you need them.
Walk Into Every Meeting Prepared
When you're ready to engage, request a pre-call brief. DOSSIRI draws on your private context and gathers current intelligence — so every conversation starts with evidence, not assumptions.
Know what matters. Before every conversation.
Life sciences sales requires precision. A misread compliance claim or a missed regulatory development can cost you a deal.
DOSSIRI is built around a single principle: every output is grounded in evidence, and you always know what DOSSIRI knows — and what it doesn't.
Sources Referenced
Every brief cites where the intelligence came from. No black boxes.
Confidence Indicated
DOSSIRI distinguishes between strong evidence and informed inference.
What You Know, First
Insider context you add takes priority. DOSSIRI builds around it, not over it.
If you sell into regulated environments, DOSSIRI was built for you.
CRO Sales
Contract research organizations
CDMO Sales
Contract development & manufacturing
Medical Device
FDA-regulated device manufacturers & distributors
GxP Technology
Validated software & systems
Regulatory Technology
Regulatory affairs & submission tools
Clinical Technology
EDC, CTMS, clinical operations
Quality & Compliance
QMS, audit, and inspection readiness
Lab Equipment
Analytical instruments & lab systems
Bioanalytical Services
Bioanalytical labs & CRO support services
Any commercial role where compliance context, regulatory knowledge, or domain specificity determines whether you win.
Built by someone who has lived the problem.
DOSSIRI was created by a regulated-industry sales professional with more than 15 years of experience across life sciences, CRO, CDMO, medical device, laboratory, compliance, and GxP technology markets.
The goal was simple: build the tool that should have existed before another seller spent hours preparing for an important conversation with incomplete information.
Know what matters before every conversation.
DOSSIRI is currently in early access. Request your spot and help shape the future of evidence-based sales intelligence for regulated industries.
Request Early Access →No credit card. No commitment. Just access.